Comparing Effectiveness of Combination of Collagen Peptide Type-1, Low Molecular Weight Chondroitin Sulphate, Sodium Hyaluronate, and Vitamin-C Versus Oral Diclofenac Sodium in Achilles Tendinopathy: A Prospective Randomized Control Trial
| Autor: | Upinderpal Singh, Abhimanyu Vasudeva, SL Yadav, Srikumar Venkataraman, Nishat Ahmed Sheikh, Sanjay Wadhwa, Arun Choudhary, Shivanand Gamanagati, Samantak Sahu, Gita Handa |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
medicine.medical_specialty
Physical Medicine & Rehabilitation Heel chondroitin sulphate Visual analogue scale Sodium hyaluronate Gastroenterology collagen peptide type 1 law.invention chemistry.chemical_compound Diclofenac Randomized controlled trial law Internal medicine medicine vas sodium hyaluronate Achilles tendon ultrasound achilles tendinopathy business.industry General Engineering Diclofenac Sodium medicine.disease medicine.anatomical_structure chemistry Tendinopathy vitamin - c business medicine.drug |
| Zdroj: | Cureus |
| ISSN: | 2168-8184 |
| DOI: | 10.7759/cureus.19737 |
| Popis: | Background Achilles tendinopathy, a common cause of heel pain, is primarily considered mechanical in origin, but its pathogenesis and treatment lack consensus. Molecules such as collagen peptide type-1, low molecular weight chondroitin sulphate, sodium hyaluronate and vitamin C have been shown to act as building blocks of tendon structure, and oral supplementation of these have promising results in Achilles tendinopathy. Methods This study was a prospective randomized control trial to compare the effectiveness of oral diclofenac sodium versus a nutraceutical combination of collagen peptide type-1, chondroitin sulphate, sodium hyaluronate, and vitamin C in the treatment of Achilles tendinopathy on pain and ultrasonographic structures. A total of 40 patients satisfying inclusion and exclusion criteria were randomly allocated into two groups and were given the nutraceutical combination in group A and diclofenac sodium in group B. The patient evaluation was done at baseline, six-week, and 12-week intervals in terms of VAS (Visual Analogue Scale) and tendo-Achilles thickness by ultrasound. Results Both nutraceutical combination and diclofenac reduced pain in persons with Achilles tendinopathy. The nutraceutical combination had a statistically significant better outcome in reducing pain at the end of 12 weeks. On ultrasound, both the interventions reduced Achilles tendon anteroposterior and mediolateral thickness by the end of 12 weeks. Although there was no absolute significant intergroup difference, the percentage change was more in the nutraceutical group in the case of anteroposterior thickness. Conclusion Combining collagen peptide type-1, low molecular weight chondroitin sulphate, sodium hyaluronate, and vitamin C is more effective than oral diclofenac in controlling pain in Achilles tendinopathy. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|